GLP-1 medications, including semaglutide, liraglutide, and tirzepatide, are increasingly used for weight loss
A1C levels set by your healthcare provider can help you gauge the efficacy of your treatment
Many insurance plans cover Ozempic for people with Type 2 diabetes
By targeting the brain areas that regulate food and hunger, semaglutide suppresses appetite
Watch for symptoms of hypoglycemia: shakiness, sweating, confusion, rapid heartbeat
[168] [169] In June 2025, the European Medicines Agency recommended that the product information for semaglutide medicines be updated to include non-arteritic anterior ischemic optic neuropathy (NAION) as a very rare side effect, [170] while the World Health Organization concluded that the risk management plan for semaglutide should be revised to include NAION as a potential risk